Skip to main content

Share story

Science

Testing LLMs on superconductivity research questions

Testing LLMs on superconductivity research questions Image: Primary
Google Research scientists tested six large language models on expert-level questions about high-temperature superconductivity. The study, published in the Proceedings of the National Academy of Sciences, compared four models with full web access against two systems that used curated sources. A panel of experts scored the responses on six metrics. NotebookLM and a custom-built retrieval-augmented generation system performed best overall. Both systems drew from a library of 1,726 sources that included experimental papers and 15 review articles selected by 12 international experts in the field. Models relying on open web sources tended to mix established theories with speculative ones. The evaluation used 67 questions on topics such as doping levels in LSCO and evidence for quantum critical points in cuprates. NotebookLM scored highest for providing evidence and for offering comprehensive answers with a balance of perspectives. The custom system ranked next in most categories. The models showed weaknesses in temporal context and in interpreting tables and images from scientific papers. The work was a collaboration with Cornell University and Harvard University.
Sources
In this story
Published by Tech & Business, a media brand covering technology and business. This story was sourced from Google Research and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Capital
Capital

Nominal raises $240 million at a $3 billion valuation

Nominal has raised $240 million at a $3 billion valuation, triple its valuation in a funding round earlier this year, Bloomberg reports. The startup builds software to make manufacturing more efficient.

Capital Products
Capital Products

Onodrim raises $300M to acquire European defence and industrial suppliers

Amsterdam-based Onodrim Industries has raised $300M in a round led by Lux Capital, valuing the defence group at $1.3bn, the company said Monday. Other investors include General Catalyst, Lakestar and Altimeter. The financing follows its €40M seed round in February.

Capital
Capital

SRTD Biotech raises €31.5 million for targeted RNA therapies

SRTD Biotech has completed an oversubscribed €31.5 million seed financing to develop RNA therapies designed to act selectively inside diseased cells. Mérieux Equity Partners led the round, with NRW.BANK and Boehringer Ingelheim Venture Fund joining as co-leads.